佰仁医疗
(688198)
| 流通市值：94.22亿 | | | 总市值：94.22亿 |
| 流通股本：1.38亿 | | | 总股本：1.38亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 253,854,015.44 | 143,555,037.4 | 620,150,252.21 | 381,722,916.02 |
| 营业总成本 | 219,576,901.03 | 96,432,215.75 | 434,540,759.53 | 305,076,828.91 |
| 其他经营收益 | | | | |
| 营业利润 | 46,418,727.87 | 49,488,673.67 | 211,992,337.62 | 101,125,894.99 |
| 利润总额 | 44,998,471.72 | 49,525,088.97 | 206,129,731.5 | 95,373,544.55 |
| 净利润 | 42,250,525.44 | 43,378,423.48 | 179,682,344.8 | 83,130,963.94 |
| 每股收益 | | | | |
| 其他综合收益 | -60,128.28 | -189,467.66 | -258,966.37 | -179,256.27 |
| 综合收益总额 | 42,190,397.16 | 43,188,955.82 | 179,423,378.43 | 82,951,707.67 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 724,133,905.67 | 850,172,079.64 | 903,748,317.01 | 584,371,897.11 |
| 非流动资产: | | | | |
| 非流动资产合计 | 734,574,367.58 | 743,806,502.64 | 719,286,905.17 | 904,291,733.48 |
| 资产总计 | 1,458,708,273.25 | 1,593,978,582.28 | 1,623,035,222.18 | 1,488,663,630.59 |
| 流动负债: | | | | |
| 流动负债合计 | 135,780,294.32 | 157,510,379.65 | 227,367,802.21 | 177,075,690.03 |
| 非流动负债: | | | | |
| 非流动负债合计 | 84,543,646.59 | 79,537,984.31 | 82,458,865.89 | 77,383,765.65 |
| 负债合计 | 220,323,940.91 | 237,048,363.96 | 309,826,668.1 | 254,459,455.68 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,253,735,774.46 | 1,368,643,181.89 | 1,326,924,610.71 | 1,245,797,918.96 |
| 股东权益合计 | 1,238,384,332.34 | 1,356,930,218.32 | 1,313,208,554.08 | 1,234,204,174.91 |
| 负债和股东权益合计 | 1,458,708,273.25 | 1,593,978,582.28 | 1,623,035,222.18 | 1,488,663,630.59 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 325,381,782.29 | 171,804,848.24 | 672,122,076.02 | 453,111,617.88 |
| 经营活动现金流出小计 | 324,886,630 | 160,360,570.51 | 474,329,046.35 | 353,224,674.21 |
| 经营活动产生的现金流量净额 | 495,152.29 | 11,444,277.73 | 197,793,029.67 | 99,886,943.67 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 693,937,211.76 | 329,796,991.37 | 954,035,188.83 | 832,122,921.55 |
| 投资活动现金流出小计 | 510,849,311.35 | 274,263,456.53 | 1,132,796,464.77 | 935,760,911.4 |
| 投资活动产生的现金流量净额 | 183,087,900.41 | 55,533,534.84 | -178,761,275.94 | -103,637,989.85 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 31,000,000 | - | 80,333,603.35 | 80,333,603.35 |
| 筹资活动现金流出小计 | 185,759,383.11 | 25,801,422.29 | 115,512,969.01 | 113,392,927.12 |
| 筹资活动产生的现金流量净额 | -154,759,383.11 | -25,801,422.29 | -35,179,365.66 | -33,059,323.77 |
| 汇率变动对现金及现金等价物的影响 | -155,850.69 | -49,856.45 | -142,375.25 | -114,344.48 |
| 现金及现金等价物净增加额 | 28,667,818.9 | 41,126,533.83 | -16,289,987.18 | -36,924,714.43 |
| 期末现金及现金等价物余额 | 67,927,638.97 | 80,386,353.9 | 39,259,820.07 | 18,625,092.82 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 28,667,818.9 | - | -16,289,987.18 | - |
最新报告期：2026-09-03| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东方财富证券 | 王舫朝 | 1.82 | 2.76 | 3.73 | 2026-09-03 |
| 中银证券 | 刘恩阳 | 1.50 | 2.40 | 3.20 | 2026-08-31 |